top of page


Journey of 2Sevnty Bio - Spin-off, Key Onco-deals, and Acquisition
🤝 Bristol Myers Squibb is set to acquire 2seventy bio in an all-cash transaction valued at approximately $286 million. After...
Oncofocus Team
Jun 201 min read


CGT Watch Newsletter: March'25 Edition
Dear Readers, Welcome to our inaugural CGT Watch newsletter! We’re excited to bring you monthly highlights on novel targets, innovative...
Oncofocus Team
Mar 206 min read


Understanding Multiple Myeloma: An Infographic Overview
Since March is Multiple Myeloma Awareness Month, we at Oncofocus have created an informative infographic highlighting the current...
Oncofocus Team
Mar 29, 20231 min read
bottom of page